Hepatitis B

Role of HBV markers in differential diagnosis

Since the clinical presentation of acute viral hepatitis often shares overlapping features, establishing a definitive etiological diagnosis relies on a process of elimination and the detection of specific antigens and antibodies.

When acute viral hepatitis of undetermined etiology is suspected (e.g., in the presence of cytolysis syndrome and hepatomegaly), differential screening is performed first. To confirm or rule out hepatitis B virus infection, the following serological markers must be tested:

• HBsAg (hepatitis B surface antigen) is the primary screening marker for infection.
• HBcor IgM (or anti-HBcor IgM) are specific class M antibodies to the core antigen, indicating the acute phase of infection.

Negative results for these markers (along with markers for hepatitis C and HIV infection) reliably rule out parenterally transmitted hepatitis.

Differences in epidemiological history

A crucial step in the differential diagnosis of hepatitis B is taking a thorough epidemiological history. Unlike hepatitis A (HAV) and hepatitis E (HEV), which are transmitted via the fecal-oral route (through contaminated water, food, or close contact in overcrowded settings), hepatitis B features a parenteral transmission mechanism.

The absence of a history of invasive procedures, parenteral manipulations, or other risk factors for contact with contaminated blood, in a patient visiting regions endemic for enteral hepatitis, significantly lowers the likelihood of an HBV diagnosis.

General clinical and laboratory syndromes of hepatitis

Before the results of the specific serological panel (HBsAg, HBcor IgM) are available, the clinical and laboratory picture may demonstrate classic syndromes common to viral liver diseases:

1. Cytolysis syndrome: massive hepatocyte destruction accompanied by a sharp (dozens of times) increase in aminotransferase activity (ALT, AST) on routine blood biochemistry. This is the earliest and most reliable marker of hepatitis development.
2. Cholestasis syndrome: impaired bile flow manifested by hyperbilirubinemia (predominantly direct fraction), elevated alkaline phosphatase (ALP), and gamma-glutamyl transferase (GGT).
3. Hepatosplenomegaly syndrome: enlargement of the liver (hepatomegaly) and, in some cases, the spleen.
4. Dyspeptic and intoxication syndromes: typical of the initial stages of the disease.

Management of close contacts

When a patient with viral hepatitis is identified, screening of contacts should include a broad serological panel. For instance, in family clusters where markers of parenteral hepatitis are detected in one family member (e.g., the wife), the evaluation scope for close contacts (such as the spouse) must be promptly and appropriately expanded to rule out asymptomatic or inapparent infection.

Briefly: answers to topical questions

Class and exam questions

What else to study on this topic

• Clinical interpretation of isolated ALT and AST elevation (cytolysis syndrome).
• Differential diagnosis of icteric and anicteric variants of viral hepatitis.
• Key features in interpreting cholestasis syndrome in liver disease.
• Inapparent and subclinical forms of viral hepatitis: detection strategies.

Other topics in the section "Viral Hepatitis and HIV"

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.